郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价The first recombinant FVIII produced in human cells--an update on its clinical development programme.

期刊：Haemophilia : the official journal of the World Federation of Hemophilia发表年份：2014作者：L A Valentino; C Negrier; G Kohla; A Tiede; R Liesner; D Hart; S Knaub
阅读更多 →

药效评价Adaptive and pathological inhibition of neuroplasticity associated with circadian rhythms and sleep.

期刊：Behavioral neuroscience发表年份：2014作者：H Craig Heller; Norman F Ruby; Asya Rolls; Megha Makam; Damien Colas
阅读更多 →

药效评价[In vitro safety evaluation of nanomaterials--cellular response to metal oxide nanoparticles].

期刊：Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan发表年份：2014作者：Kazuo Isama
阅读更多 →

药效评价Synthesis and biological evaluation of glucagon-like peptide-1 receptor agonists.

期刊：Archives of pharmacal research发表年份：2014作者：Yu-Juan Zhang; Liu-Lan Shen; Hyae-Gyeong Cheon; Yong-Nan Xu; Jin-Hyun Jeong
阅读更多 →